| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 244.90M | 226.30M | 204.00M | 172.90M | 106.00M |
| Gross Profit | 179.50M | 223.40M | 201.20M | 111.40M | 51.60M |
| EBITDA | 93.40M | 83.40M | 70.80M | 56.20M | 25.10M |
| Net Income | 7.40M | 4.40M | -8.40M | -19.30M | -35.40M |
Balance Sheet | |||||
| Total Assets | 615.90M | 585.60M | 571.50M | 595.60M | 564.70M |
| Cash, Cash Equivalents and Short-Term Investments | 3.00M | 3.00M | 1.50M | 5.40M | 7.30M |
| Total Debt | 409.70M | 401.80M | 398.10M | 420.40M | 380.60M |
| Total Liabilities | 474.20M | 454.00M | 443.50M | 461.60M | 412.60M |
| Stockholders Equity | 141.70M | 131.60M | 128.00M | 134.00M | 152.10M |
Cash Flow | |||||
| Free Cash Flow | 56.80M | 55.10M | 55.80M | 19.40M | 11.40M |
| Operating Cash Flow | 97.90M | 95.10M | 79.50M | 63.10M | 37.10M |
| Investing Cash Flow | -51.20M | -39.50M | -23.40M | -48.70M | -25.70M |
| Financing Cash Flow | -46.70M | -54.10M | -60.00M | -16.30M | -7.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £435.01M | 12.45 | 22.81% | 4.36% | 8.79% | 17.06% | |
74 Outperform | £126.19M | 10.13 | 20.23% | 3.00% | 16.79% | 26.31% | |
66 Neutral | £308.94M | 35.45 | 5.35% | ― | 8.74% | ― | |
66 Neutral | £1.57B | 8.30 | 6.46% | ― | 3.87% | 18.31% | |
66 Neutral | £4.15B | 6.31 | 7.68% | 3.80% | -2.12% | 8.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £631.18M | 8.99 | 15.81% | 1.50% | 4.52% | 50.39% |